| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |